The collapse of Silicon Valley Bank, a firm popular with tech startups and investors, could have lingering effects on the digital health ecosystem as the sector adjusts to a slowing funding environment, said venture…
Continue Reading
Funding to Accelerate Reach of Solutions, Already on Pace to Impact One Million Patient Lives in 2023
Vital, a leading artificial intelligence (AI)-driven digital health company improving the patient experience, today announced that it has raised…
The top story ViVE2023 wasn’t a major product launch, new legislation, or a mega-merger. Instead, the entire industry seems to be waiting for better times to arrive. Vendors are waiting for the economy to…
Continue Reading
What You Should Know:– Inato, a technology platform that connects pharma companies (trial sponsors) with community-based trial sites raises $20M in new funding (A2) led by Cathay Innovation with participation from existing investor Obvious…
Continue Reading
CVS Health Ventures leads with Cobalt Ventures, F-Prime, Frist Cressey, and Autism Impact Fund
SpectrumAi, a company developing innovative solutions to improve autism care, today announced that it closed up to $20 million in Series…
What You Should Know:Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the…
Continue Reading
Company launches the first-of-its-kind comprehensive nationwide payer coverage network, offering clients everything they need from first visit to final payment
OpenLoop, a leader in white-label telehealth support services powering virtual and hybrid care across the…
What You Should Know:– Vital, an artificial intelligence (AI)-driven digital health company improving the patient experience, today announced that it has raised $24.7M in Series B funding to fuel expansion and support the rapid growth…
Continue Reading
Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored $73 million in a Series B funding round led by FoundersX Ventures, bringing its total raise to $93 million. All existing…
Continue Reading
Since its initial funding last year, Protai has launched collaborations with leading hospitals, opened a wet lab and expanded its advisory board with world-renowned oncology experts, including MD Anderson’s CSO, Prof. Giulio Draetta
Protai, a…
